DuPont de Nemours (DD) insider schedules Rule 144 stock sale and reports prior trades

Rhea-AI Filing Summary

DuPont de Nemours, Inc. insider plans stock sale under Rule 144. A holder intends to sell 1,922 shares of DuPont de Nemours common stock through Merrill Lynch on the NYSE, with an aggregate market value of $79,724.56. These shares were acquired on 12/31/2025 through the vesting of a restricted stock unit award granted under the company’s equity compensation plan.

As context, DuPont de Nemours had 418,975,324 common shares outstanding. Over the prior three months, the same seller disposed of 72,958 common shares for gross proceeds of $2,993,940.97. By signing the notice, the seller represents that they are not aware of undisclosed material adverse information about the company’s current or prospective operations.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Merrill Lynch 225 Liberty St Floor 37 New York NY 10281	1922	79724.56	418975324	01/05/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	12/31/2025	Vesting of restricted stock unit award	DuPont de Nemours, Inc.			1922	12/31/2025	Granted as part of issuer equity compensation plan

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Steven Larrabee 974 CENTRE ROAD BUILDING 730 WILMINGTON DE 19805	Common Stock	12/09/2025	72958	2993940.97

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What insider transaction does DuPont de Nemours (DD) disclose in this notice?

The notice describes an intended sale of 1,922 shares of DuPont de Nemours common stock under Rule 144, to be executed through Merrill Lynch on the NYSE, with an aggregate market value of $79,724.56.

How were the 1,922 DuPont de Nemours (DD) shares being sold acquired?

The 1,922 common shares to be sold were acquired on 12/31/2025 via the vesting of a restricted stock unit award granted as part of DuPont de Nemours, Inc.’s equity compensation plan.

How many DuPont de Nemours (DD) shares are outstanding according to this filing?

The filing reports that there were 418,975,324 DuPont de Nemours, Inc. common shares outstanding, providing a baseline for the company’s share count.

What recent DuPont de Nemours (DD) stock sales has the insider made in the last three months?

During the past three months, the seller, Steven Larrabee, sold 72,958 shares of DuPont de Nemours common stock on 12/09/2025 for gross proceeds of $2,993,940.97.

Which broker and exchange are involved in the planned DuPont de Nemours (DD) share sale?

The planned sale of DuPont de Nemours common stock will be executed through Merrill Lynch, with trades to occur on the NYSE, as indicated in the notice.

What representation does the seller make about DuPont de Nemours (DD) in this Rule 144 notice?

By signing the notice, the seller represents that they do not know any material adverse information about DuPont de Nemours, Inc.’s current or prospective operations that has not been publicly disclosed.